Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
Titel:
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
Auteur:
Sacco, Assuntina G Chen, Ruifeng Worden, Francis P Wong, Deborah J L Adkins, Douglas Swiecicki, Paul Chai-Ho, Wanxing Oppelt, Peter Ghosh, Debanjali Bykowski, Julie Molinolo, Alfredo Pittman, Emily Estrada, M Valeria Gold, Kathryn Daniels, Gregory Lippman, Scott M Natsuhara, Amanda Messer, Karen Cohen, Ezra E W